Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.

Eli Lilly CEO Dave Ricks took a stand against Trump's tariffs in a Q1 earnings call. The medicine company has strong operations for obesity and weight loss drugs in Ireland.

Global pharmaceutical shares are slumping Monday after President Donald Trump said he is looking to slash the price of ...

Shares of pharmaceutical companies dropped early Monday after President Donald Trump said he would lower the cost of ...

Patients will likely eventually see higher prices and drug shortages under President Trump's plan to assess tariffs on prescription drug imports.

US drug prices are up to five times higher than in other developed nations. Trump's order requires US drug prices to align ...

The U.S. Food and Drug Administration has cleared Fujirebio Diagnostics' blood test to diagnose Alzheimer's disease, the regulator said on Friday, making the device the first of its kind to detect ...

President Trump recently warned big drugmakers that ... the president warned that a "tariff wall" is coming. Although AbbVie, Eli Lilly, and Johnson & Johnson manufacture many of their products ...